Tuis1PG • FRA
add
Aker Biomarine ASA
Vorige sluiting
€5,56
Dagwisseling
€5,63 - €5,63
Jaarwisseling
€3,80 - €8,91
Gemiddelde volume
39,00
P/V-verhouding
-
Dividend-opbrengs
-
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 50,80 m | 4,74% |
Bedryfskoste | 20,20 m | -11,79% |
Netto inkomste | -3,10 m | 73,95% |
Netto winsgrens | -6,10 | 75,14% |
Wins per aandeel | — | — |
EBITDA | 4,10 m | -57,73% |
Effektiewe belastingkoers | -42,86% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 16,00 m | -50,00% |
Totale bates | 389,60 m | -52,11% |
Totale aanspreeklikheid | 219,00 m | -52,27% |
Totale ekwiteit | 170,60 m | — |
Uitstaande aandele | 87,69 m | — |
Prys om te bespreek | 2,85 | — |
Opbrengs op bates | -0,13% | — |
Opbrengs op kapitaal | -0,15% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | -3,10 m | 73,95% |
Kontant van bedrywe | -10,90 m | -626,67% |
Kontant van beleggings | -2,60 m | 43,48% |
Kontant van finansiering | 14,50 m | 38,10% |
Netto kontantverandering | 1,00 m | -77,27% |
Beskikbare kontantvloei | -11,14 m | -474,37% |
Meer oor
Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, FloraMarine, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION and Understory. Aker BioMarine is listed on the Oslo Stock Exchange. Wikipedia
Gestig
2006
Webwerf
Werknemers
249
